BCG Lyophilized Tuberculosis Vaccine AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Object of Purchase

  • To be procured: Immunological medicinal product – BCG Lyophilized Tuberculosis Vaccine.
  • Main technical requirements, features:
    • Must be intended for newborn vaccination and comply with the immunological medicinal product specified in Annex 5 of the National Immunoprophylaxis Program for 2024–2028 (approved by Order No. V-192 on February 12, 2024).
    • Active substance: BCG Lyophilized Tuberculosis Vaccine.
    • Trade name must be indicated.
    • ATC code: J07AN01.
    • Pharmaceutical form:…
       
      To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

BS BCG vakcina.docx

c4t_7037310_1.xml

espd-request.pdf

espd-request.xml

Pirkimo dokumentai.7z

README.txt

SS 10 priedas. Preliminarios sutarties (su 1 pr) projektas 2.docx

SS 11 priedas. Preliminariosios sutarties 2 pr. Pirkimo sutarties projektas.docx

SS 1 priedas. Terminai.docx

SS 2 priedas. Techninė specifikacija.docx

SS 3 priedas. Žalieji reikalavimai.docx

SS 4 priedas. Tiekėjų pašalinimo pagrindai.docx

SS 5 priedas. EBVPD

SS 6 priedas. Tiekėjų kv reikalavimai ir Reikalavimai nac saugumui.docx

SS 7 priedas. Pasiūlymas (pasiūlymo forma).docx

SS 8 priedas. NSRAD (deklaracijos forma).docx

SS 9 priedas. Pasiūlymo vertinimo kriterijai ir sąlygos.docx

SS_BCG vakcina.docx

Ready to get started?

Subscribe and enjoy all the benefits every day!